Slow‐Release Prostacyclin Agonist‐Immersed Sheet Implantation Suppresses Liver Fibrosis via Hippo Signaling Pathway Activation
Implantation of ONO1301SR-immersed sheets suppresses liver fibrosis via Hippo signaling pathway activation, suggesting that slow-release prostacyclin agonist may have potential as a promising therapeutic option for liver fibrosis.
Authors
- Daisaku Yamada (ORCID: https://orcid.org/0000-0002-6702-3800)
- Yuichiro Doki
- Shogo Kobayashi (ORCID: https://orcid.org/0000-0002-8828-1067)
- Takahiro Kodama (ORCID: https://orcid.org/0000-0002-6250-1324)
- Shuji Terai (ORCID: https://orcid.org/0000-0002-5439-635X)
- Hirofumi Akita (ORCID: https://orcid.org/0000-0002-3115-9466)
- Kosuke Torigata
- Wataru Fujii
- Kouichi Hasegawa (ORCID: https://orcid.org/0000-0001-5947-5471)
- Takehiro Noda (ORCID: https://orcid.org/0000-0002-6768-5783)
- Yoshiki Sawa (ORCID: https://orcid.org/0000-0001-6132-9684)
- Hiroki Imamura (ORCID: https://orcid.org/0000-0001-5363-0661)
- Hidenori Takahashi (ORCID: https://orcid.org/0000-0003-4801-3540)
- Yoshito Tomimaru (ORCID: https://orcid.org/0000-0002-4432-060X)
- Akima Harada
- Hidetoshi Eguchi
- Shinichiro Hasegawa
- Kazuki Sasaki (ORCID: https://orcid.org/0009-0006-9126-0351)
- Shigeru Miyagawa
Institutions
- Niigata University (JP)
- The University of Osaka (JP)
Publication Details
- Journal
- Hepatology Research
- Published
- 2025-06-17
- DOI
- https://doi.org/10.1111/hepr.14228
- Primary Topic
- Hippo pathway signaling and YAP/TAZ
- Type
- article
- Field-Weighted Citation Impact
- 0.00